Richard E. Champlin

Richard E. Champlin

Department of Stem Cell Transplantation and Cellular Therapy, U.T. MD Anderson Cancer Center

Affiliated withU.T. MD Anderson Cancer Center

Research Area

Biography

Richard E. Champlin has not added Biography.
If you are Richard E. Champlin and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Clinical Application of <em>Sleeping Beauty</em> and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Publication title

Cited by 53

2013

Other Publications

Article
Year
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

Blood| PubMed ID: 11861270

2002
2002
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 11939604

2002
2002
2002
2002
Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 12374452

2002
2002
2003
2003
Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications f...

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 12766883

2003
2003
2003
2004
West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America| PubMed ID: 14523768

2003
2003
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 14645431

2003
2003
Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 14682302

2003
2004
2004
Nonmyeloablative stem cell transplantation for lymphoma.

Seminars in oncology| PubMed ID: 14970933

2004
2004
Designing an ethical policy for bone marrow donation by minors and others lacking capacity.

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees| PubMed ID: 15124402

2004
2004
2004
Blood and marrow transplantation compensation: perspective in payer and provider relations.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 15205664

2004
Nonmyeloablative stem cell transplantation for chronic myeloid leukemia.

Hematology/oncology clinics of North America| PubMed ID: 15271401

2004
2004
2013
Graft--versus--breast cancer effect by allogeneic hematopoietic stem-cell transplantation: a possible new frontier.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 15314060

2004
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after pri...

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 15505610

2004
2004
2004
2004
Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 15570257

2004
2004
2005
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 15800314

2005
2006
2006
Current evaluation of imatinib and allogeneic transplant in the treatment of chronic myeloid leukemia.

Clinical advances in hematology & oncology : H&O| PubMed ID: 16258420

2003
2005
Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 16399595

2006
2006
2006
2006
2006
Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: where do we stand?

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 16737932

2006
Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 16785065

2006
2006
2006
2006
2006
2006
Cutaneous manifestations of chronic graft-versus-host disease.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 17085303

2006
2007
Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 17222753

2007
2007
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabin...

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 17382251

2007
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 17382253

2007
2007
2007
2007
2007
2007
Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 17640602

2007
2007
2007
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 17697969

2007
2007
2007
2008
2008
2008
2008
2008
Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 18342791

2008
Individual physician practice variation in hematopoietic cell transplantation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 18378566

2008
2008
2008
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 18489993

2008
2008
2008
2008
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 19041063

2008
2009
2009
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 19361747

2009
Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 19361751

2009
2009
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 19539212

2009
2009
2009
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 19660722

2009
2009
2010
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 19747634

2009
Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists| PubMed ID: 19767298

2009
The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 19822219

2010
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 19822306

2009
Receiving information on fertility- and menopause-related treatment effects among women who undergo hematopoietic stem cell transplantation: changes in perceived importance over time.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 19822307

2009
2009
Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 19896074

2009
2010
Blood stem cell transplantation in older patients.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 19911448

2009
2009
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 20005966

2010
Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 20056165

2010
Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 20304082

2010
2010
2010
2010
2010
2010
2010
2010
2010
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 20674757

2011
2011
2011
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 20946966

2011
2010
Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatc...

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 20969970

2011
Primary systemic amyloid light chain amyloidosis decompensating after filgrastim-induced mobilization and stem-cell collection.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 21060030

2011
2013
Unrelated donor transplantation for acute myelogenous leukemia in first remission.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 21087679

2011
Lymphocyte recovery predicts outcomes in cord blood and T cell-depleted haploidentical stem cell transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 21126598

2011
2011
Can Treg therapy prevent GVHD?

Blood| PubMed ID: 21252098

2011
2011
Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth t...

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 21338705

2011
Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 21396475

2011
2011
2011
2011
2011
Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 21684343

2011
Outcomes of patients treated and one human leukocyte antigen-mismatched related compared with matched unrelated donors.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 21699878

2011
Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 21767516

2011
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 21771571

2011
2012
Progress in haploidentical stem cell transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 21835146

2012
2012
2012
2011
2011
2011
2012
2011
2012
2011
2012
2012
2012
2012
2012
2010
2012
2012
2012
2011
2012
2012
2012
Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 22664751

2012
2012
A new approach to simultaneously quantify both TCR α- and β-chain diversity after adoptive immunotherapy.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 22761473

2012
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 22796535

2012
Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 22892554

2013
Fifty Years of Melphalan Use in Hematopoietic Stem Cell Transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 22922522

2012
2012
2012
2012
2012
2013
2013